Connection
Elijah Mun to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Elijah Mun has written about Carcinoma, Hepatocellular.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.692 |
|
|
|
-
Mun EJ, Green P, Berry K, Ioannou GN. No difference between direct-acting antivirals for hepatitis C in hepatocellular carcinoma risk. Eur J Gastroenterol Hepatol. 2019 01; 31(1):47-52.
Score: 0.464
-
Ioannou GN, Green P, Lowy E, Mun EJ, Berry K. Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis. PLoS One. 2018; 13(9):e0204412.
Score: 0.114
-
Ioannou GN, Green PK, Beste LA, Mun EJ, Kerr KF, Berry K. Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C. J Hepatol. 2018 Nov; 69(5):1088-1098.
Score: 0.113